Syros Pharmaceuticals, Inc. - common stock (SYRS) Social Stream



Syros Pharmaceuticals, Inc. - common stock (SYRS): $5.15

0.21 (-3.92%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add SYRS to Watchlist
Sign Up

SYROS PHARMACEUTICALS INC (SYRS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SYRS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 5 $23 $9 $17.2 $6.71 156.33%
2021-12-13 6 $23 $9 $17.2 $6.71 156.33%
2022-01-03 6 $23 $9 $17.6 $6.71 162.3%
2022-05-16 6 $23 $9 $16 $6.71 138.45%
2022-05-17 6 $23 $9 $13.5 $6.71 101.19%
2022-06-07 5 $19 $9 $11.6 $6.71 72.88%
2022-08-09 5 $19 $6 $10.8 $6.71 60.95%
2022-08-10 5 $19 $3 $9.6 $6.71 43.07%
2022-09-12 5 $190 $30 $96 $6.71 1330.7%
2022-09-19 5 $190 $27 $81.4 $6.71 1113.11%
2022-11-06 5 $100 $27 $55.4 $6.71 725.63%
2022-11-14 6 $100 $27 $55.4 $6.71 725.63%
2022-11-15 5 $100 $15 $39.666 $6.71 491.15%
2022-12-10 6 $100 $15 $39.666 $6.71 491.15%
2023-01-09 6 $100 $15 $38.5 $6.71 473.77%
2023-01-26 6 $100 $15 $37.833 $6.71 463.83%
2023-05-11 6 $100 $13 $36.666 $6.71 446.44%
2023-08-09 5 $60 $15 $26.75 $6.71 298.66%
2023-10-03 5 $48 $7 $21.5 $6.71 220.42%
2023-11-15 5 $48 $7 $23.333 $6.71 247.73%
2023-12-22 5 $37 $13 $21.666 $6.71 222.89%

The Trend in the Analyst Price Target


SYRS's average price target has moved down $18 over the prior 13 months.

SYRS reports an average of 708.46% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-26 6 100 15 37.833 4.42 755.95%
2023-05-11 6 60 13 24.000 3.32 622.89%
2023-08-09 5 60 11 25.500 3.73 583.65%
2023-10-03 5 48 7 21.500 2.80 667.86%
2023-12-06 5 48 13 25.333 4.02 530.17%

SYRS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 40 months, SYRS's average broker recommendation rating improved by 0.57.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SYRS has a lower variance in analysts' estimates than -2431.5% of all US stocks.
  • In the context of all US stocks, SYROS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 2356.65% of them.
  • In the context of stocks in the small market cap category, SYROS PHARMACEUTICALS INC's average analyst price target is greater than 1707.15% of them.
  • In the context of Healthcare stocks, SYROS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 769.32% of them.

Stocks similar to SYROS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CLSD, MRKR, and SYBX.

Is SYRS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!